First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.26 USD -4.05% Market Closed
Updated: Apr 26, 2024

ADC Therapeutics SA
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Net Change in Cash Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Net Change in Cash
-$47.8m
CAGR 3-Years
N/A
CAGR 5-Years
17%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Net Change in Cash
CHf46.9m
CAGR 3-Years
N/A
CAGR 5-Years
8%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Net Change in Cash
$177m
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Net Change in Cash
-CHf44.2m
CAGR 3-Years
0%
CAGR 5-Years
-11%
CAGR 10-Years
8%
Idorsia Ltd
SIX:IDIA
Net Change in Cash
CHf44.6m
CAGR 3-Years
N/A
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Net Change in Cash
-CHf9.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Net Change in Cash?
Net Change in Cash
-47.8m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Net Change in Cash amounts to -47.8m USD.

What is ADC Therapeutics SA's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
17%

Over the last year, the Net Change in Cash growth was 66%.